DAVID ZACCARDELLI - 05 Jan 2026 Form 3 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ Grant Levine, attorney-in-fact
Issuer symbol
SABS
Transactions as of
05 Jan 2026
Net transactions value
$0
Form type
3
Filing time
07 Jan 2026, 16:35:03 UTC
Previous filing
08 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ZACCARDELLI DAVID Director 777 W 41ST STREET, SUITE 401, MIAMI BEACH /s/ Grant Levine, attorney-in-fact 07 Jan 2026 0001627642

No securities are beneficially owned.